Pharmaceutical

Gilead Sciences reports net income rise in Q2 2024

Gilead Sciences has reported net income attributable to the company at $1.61bn, up from $1.04bn in the corresponding quarter of 2023.

Aug 11, 2024 - 04:00
Gilead Sciences reports net income rise in Q2 2024
Gilead Sciences has reported net income attributable to the company at $1.61bn, up from $1.04bn in the corresponding quarter of 2023.
Read the original article

Tags:

Previous Article

Adaptimmune leads in soft tissue sarcoma therapy with first TCR approval

Next Article

WuXi Biologics and Medigene link on T cell engagers for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: What to know about this summer’s landmark Wegovy heart health study

STAT+: What to know about this summer’s landmark Wegovy...

Jul 6, 2023

STAT+: Narcan manufacturer aims to price over-the-counter kit under $50

STAT+: Narcan manufacturer aims to price over-the-count...

Apr 21, 2023

Opinion: Excited delirium: a deadly term finally laid to rest

Opinion: Excited delirium: a deadly term finally laid t...

Oct 28, 2023